Triamcinolone Acetonide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

54 API Suppliers, 28 USDMF, 10 CEP/COS, 5 JDMF, 6 EU WC, 22 KDMF, 26 NDC API, 1 VMF, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

FINISHED DOSAGE FORMULATIONS

282 FDF Dossiers, 228 FDA Orange Book, 12 Europe, 17 Canada, 2 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML, SPRAY;TOPICAL - 0.147MG/GM, INJECTABLE;INJECTION - 40MG/ML, INJECTABLE;INJECTION - 80MG/ML, SPRAY, METERED;NASAL - 0.055MG/SPRAY, FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL, CREAM;TOPICAL - 0.025%, CREAM;TOPICAL - 0.1%, CREAM;TOPICAL - 0.5%, OINTMENT;TOPICAL - 0.025%, OINTMENT;TOPICAL - 0.1%, OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 9 SPI Pharma, 2 Seqens, 11 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 7 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 15 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 22 BASF, 1 Clariant, 2 DFE Pharma, 6 Finar, 12 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 8 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 19 Roquette, 12 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Topical, 38 Thickeners and Stabilizers, 37 Solubilizers, 28 Parenteral, 28 Fillers, Diluents & Binders, 19 Film Formers & Plasticizers, 18 Direct Compression, 17 Emulsifying Agents, 16 Co-Processed Excipients, 15 Coating Systems & Additives, 13 Surfactant & Foaming Agents, 10 Controlled & Modified Release, 8 Empty Capsules, 8 Granulation, 8 Taste Masking, 8 Rheology Modifiers, 6 Disintegrants & Superdisintegrants, 5 Lubricants & Glidants, 5 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

102 NEWS #PharmaBuzz

102 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 34 Finished Drug Prices

MARKET PLACE

26 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 1 US Exclusivities, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 2 JP, 4 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 208845 / DOSAGE - FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL

Inactive Ingredients

Ingredient Name	Flexion Therapeutics, Inc.
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311)
POLY(DL-LACTIC-CO-GLYCOLIC ACID), (75:25; 140000 MW)(1SIA8062RS)
POLYSORBATE 80(6OZP39ZG8H)
SODIUM CHLORIDE(451W47IQ8X)

Drug Product Composition: Triamcinolone Acetonide